Patrik Renblad

Director of Finance/CFO at CANTARGIA AB

Net worth: 31 355 $ as of 30/06/2026

56 year

20 connections

Health Technology

Health Services

Consumer Services

Profile

Patrik Renblad is currently the Chief Financial Officer at Cantargia AB since 2023.
Prior to this, he was the Chief Financial Officer at SynAct Pharma AB from 2022 to 2023.
He also worked as a Finance Director-R&D at LEO Pharma A. Mr. Renblad is a graduate of the University of Lund.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
CANTARGIA AB 0.06%	31/12/2024	1,41,405 ( 0.06% )	31 355 $	30/06/2026

Patrik Renblad active positions

Companies	Position	Start
CANTARGIA AB	Director of Finance/CFO	15/06/2023

All active positions of Patrik Renblad

Former positions of Patrik Renblad

Companies	Position	End
SYNACT PHARMA AB	Director of Finance/CFO	15/05/2023
LEO Pharma A/S LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services	Corporate Officer/Principal	-

See the detail of Patrik Renblad's experience

Training of Patrik Renblad

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Patrik Renblad's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
LEO Pharma A/S LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services	Health Services
University of Lund University of Lund Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Cantargia AB Cantargia AB Pharmaceuticals: MajorHealth Technology Creates and develops antibody therapeutics for the treatment of leukemia	Health Technology
SynAct Pharma AB SynAct Pharma AB Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs for treatment inflammatory diseases	Health Technology